Equities

Austar Lifesciences Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Austar Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.81
  • Today's Change0.00 / 0.00%
  • Shares traded66.00k
  • 1 Year change+39.66%
  • Beta0.8892
Data delayed at least 15 minutes, as of Feb 13 2026 07:43 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Austar Lifesciences Ltd is an investment holding company mainly engaged in providing integrated engineering solutions, as well as manufacturing and distributing pharmaceutical equipment and consumables. The Company operates three segments. The Integrated Process and Packaging Equipment & Systems segment mainly includes liquid process systems and powder-solid systems. The Consulting, Digitalization and Construction segment mainly includes design consulting, compliance service systems, as well as cleanroom and automation control systems. The Life Science Equipment and Consumables segment focuses on life science and technology consumables, advanced treatment and advanced bioprocess technologies.

  • Revenue in HKD (TTM)1.65bn
  • Net income in HKD39.82m
  • Incorporated2014
  • Employees1.45k
  • Location
    Austar Lifesciences LtdRooms 2010-2013,20th Floor, No. 1018, Changning Road, CSHANGHAI ChinaCHN
  • Websitehttps://www.austar.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AMCO United Holding Ltd42.93m25.34m241.89m30.009.543.959.545.630.02620.02620.04440.06330.27322.194.481,430,967.0016.13-17.5231.44-28.5536.1926.8159.04-60.661.91--0.3507--10.07-11.0128.02------
Yestar Healthcare Holdings Co Ltd2.19bn-183.11m268.13m479.00--0.5047--0.1223-0.0785-0.07850.94070.22791.216.193.453,498,072.00-11.15-1.02-27.03-4.1516.2617.27-9.20-1.181.20-69.310.3503---17.26-13.249,987.0635.36-1.59--
Ziyuanyuan Holdings Group Ltd643.19m-59.12m296.70m44.00--0.8395--0.4613-0.1577-0.15771.590.8220.87168.972.605,145,526.00-7.92-0.1315-11.64-0.196511.70---9.09-0.22912.04-0.88550.444--10.9151.97-463.73---43.21--
Arts Optical International Holdings Ltd1.27bn-6.08m366.95m3.40k--0.68897.760.2888-0.0157-0.01573.291.380.94364.153.38353,004.700.0241-5.100.0527-10.4529.8727.650.0255-5.340.76492.160.273--7.194.26-77.75--55.71--
Rainmed Medical Ltd26.43m-117.67m406.38m214.00--0.7382--15.38-0.1004-0.10040.02250.39280.04231.194.6397,881.08-19.20---23.73--44.22---454.20--2.38--0.0766---45.61--2.02------
Austar Lifesciences Ltd1.65bn39.82m415.19m1.45k10.430.45354.260.25110.07770.07773.231.790.70174.861.541,144,113.001.584.003.519.1220.1822.092.264.391.1674.460.30590.00-14.937.42149.3114.728.35--
ClouDr Group Ltd2.55bn-1.07bn561.76m966.00--0.516--0.2201-1.82-1.824.321.690.86552.953.462,095,225.00-38.96-79.82-70.33--33.5026.37-45.01-74.910.9896-60.820.2871---5.4946.08-59.85--78.43--
Data as of Feb 13 2026. Currency figures normalised to Austar Lifesciences Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
LGT Capital Partners AG (Investment Management)as of 31 May 20250.000.00%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.